Griffin Health Services Corporation et al v. Novo Nordisk Inc. et al
Griffin Hospital and Griffin Health Services Corporation doing business as Griffin Hospital |
Novo Nordisk Inc. |
3:2024cv01045 |
June 13, 2024 |
U.S. District Court for the District of Connecticut |
Thomas O Farrish |
Janet C Hall |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1441 Notice of Removal |
Defendant |
Docket Report
This docket was last retrieved on February 10, 2025. A more recent docket listing may be available from PACER.
Document Text |
---|
![]() |
Filing 24 First MOTION for Extension of Time to File Response/Reply as to #18 MOTION to Dismiss Plaintiffs' Complaint, #19 MOTION to Request for Judicial Notice re #18 MOTION to Dismiss Plaintiffs' Complaint until September 9, 2024 by Griffin Health Services Corporation, Griffin Hospital. (Sconziano, Matthew) |
Filing 23 NOTICE of Appearance by Matthew M. Sconziano on behalf of Griffin Health Services Corporation, Griffin Hospital (Sconziano, Matthew) |
![]() |
Set Deadlines/Hearings: Rule 26 Meeting Report due by 9/12/2024 (Barry, L.) |
Filing 21 First MOTION for Extension of Time until 9/12/2024 Rule 26(f) Report by Griffin Health Services Corporation, Griffin Hospital. (Wagner, Christopher) |
Filing 20 NOTICE of Appearance by Christopher Lee Wagner on behalf of Griffin Health Services Corporation, Griffin Hospital for Attorney Matthew Sconziano (Wagner, Christopher) |
Filing 19 MOTION to Request for Judicial Notice re #18 MOTION to Dismiss Plaintiffs' Complaint by Novo Nordisk Inc..Responses due by 8/8/2024 (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I)(Chuang, Lesley) |
Filing 18 MOTION to Dismiss Plaintiffs' Complaint by Novo Nordisk Inc..Responses due by 8/8/2024 (Attachments: #1 Memorandum in Support)(Chuang, Lesley) |
![]() |
Filing 16 STIPULATION of Dismissal of Novo Nordisk U.S. Commercial Holdings, Inc., Novo Nordisk U.S. Holdings, Inc., Novo Nordisk Pharmaceutical Industries, LP, and Novo Nordisk Pharmaceutical Industries, Inc. [Joint Stipulation] by Novo Nordisk Inc.. (Chuang, Lesley) |
![]() |
Set Deadlines/Hearings: Rule 26 Meeting Report due by 7/29/2024 (DeRubeis, B.) |
Filing 14 NOTICE of Appearance by Christopher Lee Wagner on behalf of Griffin Health Services Corporation, Griffin Hospital (Wagner, Christopher) |
Filing 13 NOTICE TO COUNSEL/SELF-REPRESENTED PARTIES : Counsel or self-represented parties initiating or removing this action are responsible for serving all parties with attached documents and copies of #8 Order on Pretrial Deadlines, #2 Notice of Appearance filed by Novo Nordisk Inc., #7 Consent MOTION for Extension of Time until July 18, 2024 Briefing schedule in connection with Plaintiffs' Complaint filed by Novo Nordisk Inc., #12 Notice of Option to Consent to Magistrate Judge Jurisdiction, #9 Electronic Filing Order, #1 Notice of Removal, filed by Novo Nordisk Inc., #5 Notice (Other) filed by Novo Nordisk Inc., 6 Notice re: Disclosure Statement, #3 Disclosure Statement filed by Novo Nordisk Inc., #4 Notice (Other) filed by Novo Nordisk Inc., #10 Standing Protective Order, #11 Standing Order re: Discovery Signed by Clerk on 6/17/2024. (Attachments: #1 Standing Order on Removed Cases)(Barry, L.) |
Filing 7 Consent MOTION for Extension of Time until July 18, 2024 Briefing schedule in connection with Plaintiffs' Complaint by Novo Nordisk Inc.. (Chuang, Lesley) |
Filing 12 Notice of Option to Consent to Magistrate Judge Jurisdiction.(Barry, L.) |
![]() |
![]() |
![]() |
![]() |
Filing 6 Notice: Pursuant to Federal Rule of Civil Procedure 7.1, a disclosure statement must be filed with a party's first appearance, pleading, petition, motion, response, or other request addressed to the Court and must be supplemented if any required information changes during the case. Signed by Clerk on 6/13/2024.(Maturo, F.) |
Judge Janet C. Hall and Judge Thomas O. Farrish added. (Hushin, Z.) |
Filing 5 NOTICE by Novo Nordisk Inc. Notice of Disclosure Pursuant to Standing Order on Removed Cases (Chuang, Lesley) |
Filing 4 NOTICE by Novo Nordisk Inc. Notice of Pending Motions (Chuang, Lesley) |
Filing 3 Disclosure Statement by Novo Nordisk Inc. identifying Corporate Parent Novo Nordisk US Commercial Holdings, Inc. for Novo Nordisk Inc.. (Chuang, Lesley) |
Filing 2 NOTICE of Appearance by Lesley P. Chuang on behalf of Novo Nordisk Inc. (Chuang, Lesley) |
Filing 1 NOTICE OF REMOVAL by Novo Nordisk Inc. from Ansonia-Milford Judicial District of the Superior Court of Connecticut, case number AAN-CV24-6056394-S. Filing fee $ 405 receipt number ACTDC-7801032, filed by Novo Nordisk Inc.. (Attachments: #1 Civil Action Cover Sheet, #2 Exhibit A - Complaint, #3 Exhibit B - NMI's Corporate Disclosure Statement, #4 Exhibit C - Civil Docket Report, #5 Exhibit D - State Court Docket)(Chuang, Lesley) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Connecticut District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.